Enhancement of bone formation in hydroxyapatite implants by rhBMP-2 coating.
The combination of hydroxyapatite (HA) implants serving as osteoconductive scaffold with growth factors is an interesting approach for the improvement of bone defect healing. The purpose of this study was to test whether recombinant human bone morphogenetic protein-2 (rhBMP-2) coating of solid HA-implants improves bone formation in a cortical bone defect. Cylindrical trephine mill defects (diameter: 9.8 mm, depth: 10 mm) were created into the cortical tibia shaft of minipigs and subsequently filled either by plain HA cylinders (Endobon) or by rhBMP-2-coated HA cylinders. Fluorochrome labeling for the evaluation of time-dependent bone formation was done on days 8, 9, and 10 postsurgery with tetracyclin-100, at days 25 and 30 with alizarin-komplexon, and finally on days 32, 37, 73, and 79 with calcein green. Twelve weeks after implantation, the tibiae were harvested and were prepared for standard histological staining, fluorochrome analysis, and histomorphometry. Coating of HA implants with rhBMP-2 led to significant enhanced new bone formation of 84.7% (+/-4.6%) of the implant area with almost complete bony incorporation compared with only 27.7% (+/-8.5%) in the uncoated HA implants (p = 0.028). In both types of implants, osteoconduction of HA led to bone ingrowth of the surrounding host bone into the implants. However, only rhBMP-2-coated implants showed multitopic de novo bone formation reflecting the osteoinductive properties of rhBMP-2 in all areas of the HA implant. This study showed that the coating of HA ceramic implants with rhBMP-2 can significantly enhance new bone formation attributable to its osteoinductive effects.
Schnettler
Reinhard
R
Department of Trauma Surgery Giessen, University Hospital of Giessen-Marburg, Giessen 35385, Germany. reinhard.schnettlert@chiru.med.uni-giessen.de
Knöss
Peter D
PD
Heiss
Christian
C
Stahl
Jens-Peter
JP
Meyer
Christof
C
Kilian
Olaf
O
Wenisch
Sabine
S
Alt
Volker
V
D000818:Animals; D001846:Bone Development; D055396:Bone Morphogenetic Protein 2 / Q000008:administration & dosage*; D017886:Durapatite; D005456:Fluorescent Dyes; D019736:Prostheses and Implants; D011994:Recombinant Proteins / Q000008:administration & dosage; D013552:Swine; D013556:Swine, Miniature
D055396:Bone Morphogenetic Protein 2; D005456:Fluorescent Dyes; D011994:Recombinant Proteins; D017886:Durapatite